The correlation between CTHRC1 and integrin β3/FAK signaling exposes the mechanisms underlying peritoneal ovarian tumor dissemination, and provides a new direction in ovarian cancer diagnosis and treatment. This evidence concerns the gene CTHRC1 and ovarian carcinoma.